These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20530321)

  • 1. Discontinuation of antiplatelet agents: don't worry, be happy?
    Chaturvedi S
    Neurology; 2010 Jun; 74(23):1850-1. PubMed ID: 20530321
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage.
    Caso V; Paciaroni M; Venti M; Alberti A; Palmerini F; Milia P; Billeci AM; Silvestrelli G; Biagini S; Agnelli G
    Cerebrovasc Dis; 2007; 24(2-3):215-8. PubMed ID: 17630480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 5. Discontinuation of perioperative antiplatelet and anticoagulant therapy in stroke patients.
    Armstrong MJ; Schneck MJ; Biller J
    Neurol Clin; 2006 Nov; 24(4):607-30. PubMed ID: 16935191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit.
    Winning J; Neumann J; Kohl M; Claus RA; Reinhart K; Bauer M; Lösche W
    Crit Care Med; 2010 Jan; 38(1):32-7. PubMed ID: 19770746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
    Moonis M; Fisher M
    Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):611-5. PubMed ID: 15030260
    [No Abstract]   [Full Text] [Related]  

  • 8. Rebound inflammation and the risk of ischemic stroke after discontinuation of aspirin therapy.
    Pijak MR
    Arch Neurol; 2006 Feb; 63(2):300-1; author reply 301. PubMed ID: 16476829
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of antiplatelet agents in stroke.
    Mousa SA
    Curr Opin Investig Drugs; 2000 Dec; 1(4):464-7. PubMed ID: 11249700
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of antiplatelet therapy in stroke prevention.
    Chesney CM
    Tenn Med; 1997 Nov; 90(11):454-5. PubMed ID: 9368453
    [No Abstract]   [Full Text] [Related]  

  • 12. [Don't worry, doc, be happy!].
    Mäulen B
    MMW Fortschr Med; 2008 Jul; 150(28-31):16-8, 20. PubMed ID: 19009702
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic and thrombolytic therapy for ischemic stroke.
    Cornett O; Ocava LC; Singh M; Malhotra S; Rosenbaum DM
    Cardiol Clin; 2008 May; 26(2):251-65, vii. PubMed ID: 18406998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
    Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin resistance in secondary stroke prevention.
    Berrouschot J; Schwetlick B; von Twickel G; Fischer C; Uhlemann H; Siegemund T; Siegemund A; Roessler A
    Acta Neurol Scand; 2006 Jan; 113(1):31-5. PubMed ID: 16367896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical procedures in patients treated with platelet function inhibitors].
    Rupprecht HJ; Blank R; Konradi D; Andreas K; Auerbach H
    Herz; 2008 Jun; 33(4):254-9. PubMed ID: 18581074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
    Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB
    Cerebrovasc Dis; 2010; 29(1):79-81. PubMed ID: 19907167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy in ischemic stroke.
    Pongrácz E; Káposzta Z
    Expert Rev Neurother; 2005 Jul; 5(4):541-9. PubMed ID: 16026237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy: views from the experts.
    Easton JD; Diener HC; Bornstein NM; Einhäupl K; Gent M; Kaste M; Sacco RL; Tijssen JG; van Gijn J
    Neurology; 1999; 53(7 Suppl 4):S32-7. PubMed ID: 10532646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.